Telemonitoring of Fetal Heart Rate in Low-Risk Pregnancies

Remote fetal surveillance is becoming a practical part of modern maternity care. Telemonitoring can allow selected pregnant patients to record fetal heart rate and maternal observations at home, with results reviewed by a midwife, obstetrician, or designated monitoring team. Used carefully, this approach may reduce unnecessary travel while preserving access to professional assessment.

The appeal is especially strong in low-risk pregnancies that become temporarily more demanding because of distance, mobility limitations, local service pressures, or the need for repeated observation. Yet fetal heart rate monitoring is not a simple home test. Its value depends on appropriate patient selection, reliable equipment, trained users, and a clear response pathway when a tracing is incomplete or abnormal.

Perinatal medicine has long combined clinical judgment, electronic fetal monitoring, neonatal expertise, and research into pregnancy outcomes. The FAOPS 2020 archive reflects that wider international setting, linking perinatal and neonatal medicine with scientific exchange across Asian and Oceania societies. Telemonitoring belongs within that same evidence-based conversation rather than replacing hands-on maternity care.

What remote fetal monitoring involves

Telemonitoring usually refers to collecting physiological data outside a hospital or clinic and sending it to a clinical team for review. In pregnancy, the central measurement may be the fetal heart rate, often recorded alongside uterine activity. Depending on the device, the system may also capture maternal pulse, blood pressure, oxygen saturation, temperature, symptoms, and fetal movement reports.

A conventional non-stress test uses external transducers placed over the abdomen to assess the fetal heart rate pattern and possible accelerations. Home systems may use portable cardiotocography, wireless sensors, or newer methods that separate maternal and fetal signals. The technology can transmit a continuous tracing, selected segments, or alerts generated by an algorithm.

The clinical meaning of a recording is shaped by gestational age, fetal movement, maternal condition, medication, and the reason for surveillance. A reassuring result is not a guarantee that a pregnancy will remain uncomplicated. Similarly, a technically poor signal does not automatically indicate fetal compromise. Remote review must therefore include context, communication, and access to in-person evaluation.

Why low-risk pregnancies may use it

Routine cardiotocography is not automatically beneficial for every uncomplicated pregnancy. In many low-risk patients, antenatal testing is offered only when symptoms, gestational age, reduced fetal movement, post-term pregnancy, or a new clinical concern creates a reason for surveillance. Unnecessary testing can produce false alarms, anxiety, additional appointments, and avoidable interventions.

Telemonitoring can be useful when a clinician has identified a specific, limited indication. Examples may include short-term observation after reduced fetal movement has been assessed, follow-up for an isolated concern, monitoring during a late-term period, or review of a patient who lives far from a maternity unit. It may also support continuity when a patient cannot easily attend frequent visits.

The phrase “low risk” should describe the current clinical assessment, not a permanent status. Hypertension, vaginal bleeding, suspected fetal growth restriction, diabetes requiring closer observation, abnormal Doppler findings, ruptured membranes, painful contractions, or a significant change in fetal movement can alter the care plan. A remote program needs rules for moving patients promptly into face-to-face assessment.

Building a safe telemonitoring pathway

Safety begins before the first tracing. The maternity team should confirm gestational age, pregnancy history, indication for monitoring, baseline maternal health, emergency contact details, and the patient’s ability to use the equipment. Language access, health literacy, internet connectivity, disability accommodations, and the availability of another adult may affect whether home monitoring is appropriate.

Training should cover sensor placement, charging, device cleaning, recording duration, fetal movement marking, and troubleshooting. Patients need plain-language instructions explaining that a device cannot diagnose every pregnancy complication. They should know which symptoms require immediate contact with maternity services, regardless of whether the tracing appears reassuring.

A telemonitoring service also requires operational safeguards. Every submitted recording should enter a queue with a defined review time, named clinical responsibility, and documented result. The patient should receive a clear message about whether monitoring is complete, whether another recording is needed, and what action to take. Unreviewed data, failed uploads, and missed appointments need active follow-up rather than passive waiting.

Privacy and cybersecurity deserve equal attention. Fetal and maternal recordings are health information, so systems should use secure transmission, controlled access, audit trails, and transparent consent procedures. Device manufacturers and hospitals should clarify where data are stored, how long they are retained, and who can see algorithmic alerts or raw tracings.

Comparing monitoring models

Different approaches answer different clinical needs. A hospital-based non-stress test provides immediate access to skilled interpretation and emergency care, while a home recording can improve convenience for carefully selected patients. Intermittent handheld Doppler checks may document a heart rate but do not provide the same information as a continuous tracing and should not be treated as equivalent.

The right model depends on indication, local staffing, equipment quality, and the reliability of escalation arrangements. A comparison can help teams define the boundaries of each option.

Reading the tracing without overreaching

Interpretation of a remote fetal heart rate recording should use the same core principles applied in clinical practice. Reviewers consider baseline rate, variability, accelerations, decelerations, recording quality, uterine activity, and the duration of an interpretable segment. They also account for gestational age and whether the patient reports normal fetal movement.

Automated classification can help prioritize recordings, but it should not operate as an independent diagnosis. Algorithms may struggle with maternal-fetal signal overlap, movement artifact, obesity, unusual fetal position, twins, or poor electrode contact. A label such as “normal” or “urgent” needs review by a clinician who can integrate the tracing with symptoms and history.

Telemonitoring is particularly unsuitable as a substitute for assessment when the concern may involve fetal structural disease. Questions about congenital heart disease, for example, require appropriate imaging and specialist evaluation. The discussion of prenatal diagnosis guidance illustrates why prenatal detection and postnatal management must be connected across specialties rather than reduced to a single heart rate reading.

An abnormal, persistent, or uninterpretable result should trigger a defined action. Depending on the circumstances, that may involve repeating the recording under supervision, arranging same-day assessment, performing ultrasound or biophysical testing, or sending the patient directly to a hospital. The threshold for escalation should be conservative when symptoms and technology do not align.

Measuring outcomes and equity

A telemonitoring program should be evaluated through clinical and service outcomes. Useful measures include unplanned hospital visits, time from abnormal recording to review, emergency deliveries, cesarean birth rates, neonatal outcomes, failed recordings, patient satisfaction, and the number of cases in which remote monitoring delayed necessary care. Reviewing false-positive alerts is important because excessive escalation can burden patients and services.

Equity must be measured rather than assumed. A smartphone, stable broadband connection, private space, transport for emergency referral, and confidence with digital tools are not universal. Programs that depend heavily on personal technology may exclude patients who could benefit from closer support. Loan equipment, telephone alternatives, interpreter services, in-person teaching, and community-based monitoring can reduce these gaps.

Cost savings should never be the only justification. A remote pathway that lowers appointment numbers but increases anxiety, missed abnormalities, or emergency transfers may be clinically unsound. Patient experience matters too: some people find home monitoring reassuring, while others feel responsible for interpreting data they cannot safely interpret themselves.

Research should compare telemonitoring with usual care in clearly defined low-risk populations. Studies need transparent reporting of eligibility, recording quality, clinician response time, intervention rates, and perinatal outcomes. Evidence from one health system may not transfer directly to another where maternity access, staffing, digital infrastructure, or referral distances differ.

Practical recommendations for clinical programs

A responsible service can use the following principles:

• Define eligibility and exclusion criteria, including symptoms and conditions that require direct assessment.
• Train patients and staff in sensor placement, fetal movement reporting, technical troubleshooting, and emergency escalation.
• Assign a named clinician or team to review every recording within a documented timeframe.
• Combine fetal heart rate data with maternal symptoms, gestational age, movement history, and relevant examination findings.
• Audit signal quality, false alerts, delayed responses, equity of access, patient experience, and neonatal outcomes.

The pathway should be reviewed regularly with patients, midwives, obstetricians, neonatologists, information-governance specialists, and technical staff. Local protocols should state exactly when a home test ends and hospital assessment begins. This boundary protects patients from both false reassurance and unnecessary alarm.

Telemonitoring works best as a coordinated extension of maternity care. It can make surveillance more accessible, but it cannot remove the need for skilled interpretation, ultrasound when indicated, physical examination, or rapid emergency services. Its success is measured by safe decisions and timely care, not by the number of recordings collected.

Healthcare organizations, researchers, and perinatal teams can use these principles to design or evaluate a fetal monitoring pathway that is clinically cautious, digitally secure, and accessible to the families it serves. Start with a defined patient group, test the escalation process in practice, and expand only when outcome data show that remote care is supporting—rather than weakening—safe pregnancy care.